多功能和高效的蛋白质协会通过化学修饰的基米林纳米系统 (SN) 进行增强的交付
Marcelina Abal-Sanisidro1,2,3, Olaia Nieto-García1, Cristina Cotelo-Costoya1
1Nano-Oncology and Translational Therapeutics group, IDIS, Complexo Hospitalario Universitario de Santiago de Compostela (CHUS), 15706, Santiago de Compostela, Spain.
Chembiochem : a European journal of chemical biology
|September 10, 2024
概括
斯芬戈米林纳米系统 (SN) 为蛋白质治疗药物提供提供了一种新的解决方案. 这些优化的系统增强了蛋白质的稳定性和生物可用性,为先进的药物开发铺平了道路.
科学领域:
- 生物技术和纳米医学
- 蛋白质治疗药物 提供 蛋白质治疗药物
背景情况:
- 蛋白质对于细胞信号传递和治疗应用至关重要,因为它们的特异性和活性.
- 蛋白质疗法的挑战包括不稳定性,展开性和低生物可用性,阻碍有效的管理.
- 研究药物输送系统和纳米技术,以改善生物分子的持续释放,生物可用性和细胞内输送.
研究的目的:
- 优化菌素纳米系统 (SN) 以提供各种各样的蛋白质.
- 评估各种化学关联策略,以在SN中进行蛋白质加载.
- 验证SNs在开发先进蛋白疗法的潜力.
主要方法:
- 研发和优化斯芬戈美林纳米系统 (SN).
- 使用不同的化学联结策略,对各种蛋白质 (10-500 kDa,不同的 pI) 进行加载.
- 使用多种分析方法对SN进行全面的表征.
- 在体外验证开发的含蛋白质的SN配方.
主要成果:
- 成功优化了用于蛋白质封装的基米林纳米系统 (SN).
- 证实了SN能够容纳广泛的蛋白质大小和同电点 (pI) 的能力.
- 试验室研究证实了SN在有效的蛋白质输送和生物活性维护方面的潜力.
结论:
- 斯芬哥米林纳米系统 (SN) 是一个有前途的平台,可以克服蛋白质治疗的挑战.
- 开发的SNs增强了蛋白质的稳定性,生物可用性和细胞内传递.
- 这项研究提供了证据,证明了SNs在蛋白质疗法的进步中的潜力.
相关概念视频
01:45Regulation of Nuclear Protein Sorting
2.5K
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
2.5K
01:43SNAREs and Membrane Fusion
10.4K
Once a transport vesicle has recognized its target organelle, the vesicular membrane needs to fuse with the target membrane to unload the cargo. Transmembrane proteins called SNAREs present on organelle membranes and their vesicles, mediate vesicle fusion.
SNAREs exist in pairs that symmetrically interact and catalyze the fusion of the lipid bilayers in vesicle and target organelle. v-SNARE in the vesicle membrane are single polypeptide chains that bind to a complementary t-SNARE, composed of 2...
SNAREs exist in pairs that symmetrically interact and catalyze the fusion of the lipid bilayers in vesicle and target organelle. v-SNARE in the vesicle membrane are single polypeptide chains that bind to a complementary t-SNARE, composed of 2...
10.4K
01:24Modified-Release Drug Delivery Systems: Site-Targeted
164
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
164
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
160
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
160